We are proud to present the winners of our first annual PM360 ELITE Awards. The ELITE (Exceptional Leaders, Innovators, Transformers and Entrepreneurs) represent the most influential people in the healthcare industry. The key word: People. This is PM360’s first award to focus solely on people—not just their work or company—but the individual.
We shine a spotlight on the most powerful minds—the thinkers who are shaping our industry. But beyond that, we provide our readers with insights into how these exceptional individuals became so successful—highlighting their greatest accomplishments, current game-changing projects and goals for the future. We also offer all of pharma the opportunity to rub elbows with this eclectic group as we honor the PM360 ELITE with an awards cocktail party, July 14th at 6:30 PM at the Standard High Line rooftop bar in New York City’s Meatpacking District.
But first, meet PM360’s ELITE inaugural class. These 60 individuals are not simply the top people in their fields—but also the industry’s preeminent leaders. And it was not easy to narrow the field down to just 60. We received a large number of nominations—from every area of the industry—that were not only compelling but brimming with enthusiasm. The nominations were more than just facts and figures detailing a person’s vast accomplishments, but passionate testimonials stressing why that person was so deserving of being honored. But ultimately we choose the 60 that represented the true crème de la crème.
And that starts with PM360’s Uber Elite—or the very best of the very best—Brenton “Brent” Saunders, the CEO of Actavis. At just 44, his accomplishments are numerous. He served as the CEO of three major pharma companies and just recently transformed Actavis—through the acquisition of Allergan—from a generics manufacturer into a top 10 company.
We also honor the ELITE in the following 12 categories:
Leaders of the Future: Up-and-comers who display the characteristics of an emerging leader.
Entrepreneurs: Visionary risk-takers who develop new companies to answer unmet needs.
Transformational Leaders: People who change the way companies operate—from instituting new organizational structures to reinvigorating stagnant businesses.
Patient Advocates: Those who work on patients’ behalf to make their voices heard and ensure their needs are met.
Disrupters: The fearless individuals who disrupt the status quo to revolutionize the industry.
Mentors: The role models others aspire to emulate.
Strategists: People with a sixth sense for what works—and the ability to predict what the evolving pharma industry needs to do to remain relevant.
Tech-know Geeks: Innovators who spearhead technological breakthroughs that reshape the industry.
Master Educators: People who revolutionize the way patients/doctors learn and absorb the information available from life science companies.
Data Miners: Individuals who specialize in analytics and can turn hordes of numbers and research into actionable insight.
Launch Experts: Marketers with significant success in bringing a new drug to market or in revitalizing markets for an older drug with a fresh campaign.
Digital Crusaders: Those who advance digital channel applications or platforms to transform marketing and/or company operations.
Dive in and learn what it takes to become ELITE.
The 2015 Elite Winners
Brenton “Brent” Saunders, Actavis
Leaders of the Future
Greg Cohen, UCB, Inc.
Tom Fussaro, Astellas Pharma US, Inc.
Meredith S. Manning, Baxter BioScience
Michael Nesrallah, Novartis Pharmaceuticals Corporation
Jeenal Shah, Sudler New York
Jeremy T. Shepler, Novo Nordisk Inc.
Charles Benaiah, watzan
Mark Heinold, PDR, LLC
Jeff Meehan, Cancer Action Now
Robert G. Previdi, PSKW, LLC
Frank Segrave, Silvergate Pharmaceuticals, Inc.
Matt Giegerich, Ogilvy CommonHealth Worldwide
Kim Johnson, PALIO
Melissa Johnston, Benchworks
Michelle Keefe, Publicis Touchpoint Solutions, Inc.
Meghan Lopresto, Boehringer Ingelheim
Anthony J. Maddaluna, Pfizer Inc. and Pfizer Global Supply
David Nakamura, Natrel
Hugh O’Neill, Mallinckrodt
Frank X. Powers, Dudnyk
Scott Shively, Depomed, Inc.
Donato Tramuto, Physicians Interactive
Timothy P. Walbert, Horizon Pharma plc
Robert Ward, Radius Health, Inc.
Lene Andersen, HealthCentral – Remedy Health Media
Karen Iannella, Boehringer Ingelheim Pharmaceuticals Inc.
Doug Ulman, Pelotonia
Michael Coffey, Roche Diabetes Care Inc.
Jim Curtis, Remedy Health Media
Elizabeth Elfenbein, The CementBloc
Peter Kirk, SERMO
Ibraheem (Ibs) Mahmood, DrugDev
Stan Woodland, CMI/Compas
Thomas P. McDonnell, Shire Pharmaceuticals, Inc.
Claire Scott, Genentech
Shilpa Shah-Mehta, Novartis Oncology
Gwen D. Washington, Shire Pharmaceuticals, Inc.
Deborah Wood, DWA Healthcare Communications Group and Avant Healthcare
Matt Barry, Astellas Pharma US, Inc.
Jay Carter, AbelsonTaylor
Danielle Dunne, Allidura Consumer, part of inVentiv Health
Jesus Leal, Novartis
Mario R. Nacinovich Jr., MSc, AXON
Danny Villeneuve, Shire
Kendra Fanara, Janssen Therapeutics
Adam Kaplin, MD, PhD, Johns Hopkins University School of Medicine
David Windhausen, Intouch Solutions
Pasqual Zottola, Acorda Therapeutics, Inc.
Paula van de Nes, PhD, LLNS
Malcolm Bohm, Liquid Grids Inc.
Asaf Evenhaim, Crossix Solutions
Manish Sood, Reltio, Inc.
David Green, RPh, Bausch & Lomb, Inc., A Valeant Pharmaceuticals North America LLC Company
Jonathan Kuhn, Acorda Therapeutics, Inc.
Andrew J. Watson, Wockhardt USA
Dave Guiga, AstraZeneca
Trish Nettleship, UCB, Inc.
Nancy Phelan, Bristol-Myers Squibb
Michael Russo, Acorda Therapeutics, Inc.